AP
Angad Pratap Barnala
About Angad Pratap Barnala
Data last updated:
Angad Pratap Barnala is a Director at Dhaula Ventures Private Limited (since 2026), Director at Angad And Aaron Hospitality Group Private Limited (since 2025) and Director at Japson Pharmaceuticals (Pb) Limited (since 2019). The companies operate in Consumer Services and Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Aug 2026 | 2026 | Active | ||
| Director | 11 Aug 2025 | 2025 | Active | ||
| Director | 03 May 2019 | 1983 | Active |
Board colleagues of Angad Pratap Barnala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhay Barnala | 08441847 | Dhaula Ventures Private Limited , Japson Pharmaceuticals (Pb) Limited | Director |
| Aaron Shanan James | 11237931 | Angad And Aaron Hospitality Group Private Limited | Director |
| Pervesh Bir | 10463048 | Japson Pharmaceuticals (Pb) Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Angad Pratap Barnala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Angad Pratap Barnala
Angad Pratap Barnala currently holds 3 directorships: Dhaula Ventures Private Limited (Director, since 03 Aug 2026); Angad And Aaron Hospitality Group Private Limited (Director, since 11 Aug 2025); Japson Pharmaceuticals (Pb) Limited (Director, since 03 May 2019).
Angad Pratap Barnala was first appointed on 03 May 2019 as Director at Japson Pharmaceuticals (Pb) Limited. The most recent appointment on record is 03 Aug 2026 at Dhaula Ventures Private Limited.
The current boards of Angad Pratap Barnala's companies include Abhay Barnala (Dhaula Ventures Private Limited), Aaron Shanan James (Angad And Aaron Hospitality Group Private Limited), Pervesh Bir (Japson Pharmaceuticals (Pb) Limited).